© 1995 by European Society of Cardiology
Copyright © 1995, European Society of Cardiology
Selective increase in endothelin-1 and endothelin A receptor subtype in the hypertrophied myocardium of the aorto-venacaval fistula rat
Department of Clinical Pharmacology, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
* Correspondence to Dr Nunez.
Objective: At present little is known about the factors that regulate the expression of the endothelins and their receptors in cardiac tissue in vivo. The aim of this study was to investigate changes in expression of the endothelins (ET-1, ET-2, and ET-3) and their receptors (ETAR and ETBR) in the hypertrophied heart of the aortovenocaval (AV) fistula rat. Methods: Reverse transcription-polymerase chain reaction (RT-PCR) was used to quantify cardiac mRNA expression of the endothelins and their receptors during the development of cardiac hypertrophy, while radioligand binding was employed to quantify the amount of [125I]-ET-1 binding to cardiac membranes. Tissue and plasma concentrations of ET-1 were measured by radioimmunoassay. Results: In control sham operated animals, ET-1 mRNA was ~fivefold greater in atria than in ventricles (P < 0.05), but there were no atrioventricular differences in ET-2 or ET-3 mRNA. In the AV fistula rats there was a prompt three- to fourfold increase in ET-1 mRNA in atria and a progressive five- to sevenfold rise in ventricles during cardiac hypertrophy. There were no changes in ET-2 or ET-3 transcript prevalences, except for a late rise (35 d) in ET-2 mRNA levels in left ventricle. Consistent with ET-1 mRNA measurements, immunoreactive endothelin levels were increased by 7 d in atria, but not in ventricles. In control rat hearts, ETAR mRNA levels were similar in atria and ventricles, but the prevalence of ETBR was ~sevenfold greater in the former. ETAR mRNA prevalence increased with hypertrophy in all chambers, while ETBR transcript levels were raised only in the right ventricle. There was no significant difference in [125I]-ET-1 binding between atrial samples from 35 d control and 35 d AV fistula rats, suggesting rapid turnover of endothelin receptors balanced by increased transcription from the ETAR gene. Conclusions: During cardiac hypertrophy in AV fistula rats there is increased activity of the endothelin system mediated principally by ET-1 and the ETAR subtype.
KEYWORDS endothelin receptor; heart; polymerase chain reaction; radioimmunoassay; ligand binding
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Szokodi, F. Horkay, B. Merkely, F. Solti, L. Geller, P. Kiss, L. Selmeci, V. Kekesi, O. Vuolteenaho, H. Ruskoaho, et al. Intrapericardial infusion of endothelin-1 induces ventricular arrhythmias in dogs Cardiovasc Res, May 1, 1998; 38(2): 356 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A Brown, R. A.D Rutherford, D. J.R Nunez, John Wharton, D. G Lowe, and M. R Wilkins Downregulation of natriuretic peptide C-receptor protein in the hypertrophied ventricle of the aortovenocaval fistula rat Cardiovasc Res, December 1, 1997; 36(3): 363 - 371. [Abstract] [Full Text] [PDF]
|
|